ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN?

Abstract

Problem of anticoagulant choice in patients with acute coronary syndrome (ACS) is discussed. Results of the main trials on low-molecular heparin therapy in patients with ACS as well as recommendations of European cardiology society and American heart association are presented. Peculiarities of other therapies (thrombin inhibitors, Ха-factor inhibitors) in ACS are surveyed.

Keywords

• acute coronary syndrome
• anticoagulants
• low-molecular heparins